Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Johannesburg Stock Exchange  >  Aspen Pharmacare Holdings Limited    APNJ   ZAE000066692

ASPEN PHARMACARE HOLDINGS LIMITED (APNJ)
My previous session
Most popular
  Report  
End-of-day quote. End-of-day quote  - 09/21
174.6 ZAR   -1.51%
09/17ASPEN PHARMACAR : Acquisition
CO
09/13South Africa's Aspen sells infant formula business to Lactalis fo..
RE
09/13ASPEN PHARMACAR : Slide show results
CO
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   End-of-day quote. End-of-day quote Johannesburg Stock Exchan…
09/17/2018 09/18/2018 09/19/2018 09/20/2018 09/21/2018 Date
192.55 188.25 174.35 177.27 174.6 Last
5557636 3087345 4927756 5534247 3262623 Volume
+0.90% -2.23% -7.38% +1.67% -1.51% Change
Financials (ZAR)
Sales 2019 44 185 M
EBIT 2019 11 322 M
Net income 2019 6 327 M
Debt 2019 38 734 M
Yield 2019 1,94%
Sales 2020 46 053 M
EBIT 2020 12 188 M
Net income 2020 8 567 M
Debt 2020 34 381 M
Yield 2020 2,18%
P/E ratio 2019 9,09
P/E ratio 2020 9,48
EV / Sales2019 2,68x
EV / Sales2020 2,48x
Capitalization 79 696 M
More Financials
Company
Aspen Pharmacare Holdings Ltd. engages in the manufacture and supply of branded and generic pharmaceutical products.The firm operates through the following segments: Commercial Pharmaceuticals, Nutritionals, and Manufacturing.The Commercial Pharmaceuticals segment comprises of the Anaesthetic;... 
More about the company
Surperformance© ratings of Aspen Pharmacare Holdings
Trading Rating : Investor Rating :
More Ratings
Latest news on ASPEN PHARMACARE HOLDINGS
09/17ASPEN PHARMACARE HOLDINGS LIMITED : Acquisition
CO
09/13ASPEN PHARMACARE : concludes sale of Nutritionals
AQ
09/13South Africa's Aspen sells infant formula business to Lactalis for $865 milli..
RE
09/13ASPEN PHARMACARE HOLDINGS LIMITED : Annual results
CO
09/13ASPEN PHARMACARE HOLDINGS LIMITED : Slide show results
CO
09/12ASPEN PHARMACARE : in talks to sell infant formula unit
AQ
09/12ASPEN PHARMACARE : in talks to sell infant formula unit
AQ
09/10ASPEN PHARMACARE HOLDINGS LIMITED : annual earnings release
08/13ASPEN PHARMACARE : ‘strategy ambiguity’ in spotlight
AQ
07/20ASPEN PHARMACARE : Are Strong-Armed Tactics By Big Pharma Behind the Country's B..
AQ
More news
Sector news : Generic Pharmaceuticals
02:06aJ&J UNIT : Esketamine Study Didn't Show Statistical Significance for Primary End..
DJ
09/21JOHNSON & JOHNSON : J&J Unit Agrees To Sell Sterilization Unit for $2.7 Billion
DJ
09/21EMA Nod to Eli Lilly Drug Stokes Competition in Migraine Prevention Market
DJ
09/21Triple Set of EMA Recommendations for Novartis Drugs
DJ
09/21GlaxoSmithKline, Innoviva Get Positive CHMP Opinion on Expanded COPD Indicati..
DJ
More sector news : Generic Pharmaceuticals
Latest Tweets
09/14Aspen Pharmacare is down 35% in the last 10 days. Eina! I wrote about them in..
4
09/14$109J Pharmacare Holdings Ltd. 1 director bought: A director at Aspen Pharma.. 
08/02Aspen Pharmacare wants to play in the big leagues: Read full story for latest.. 
08/01Aspen Pharmacare wants to play in the big leagues
2
05/08VIDEO | Aspen Pharmacare set to create 500 new jobs
1
More tweets
Qtime:7
News from SeekingAlpha
09/14Aspen Pharmacare Holdings plc ADR 2018 Q4 - Results - Earnings Call Slides 
03/09Aspen Pharmacare Holdings Plc ADR 2018 Q2 - Results - Earnings Call Slides 
2017Aspen Pharmacare Holdings (APNHY) Investor Presentation - Slideshow 
2017Aspen Pharmacare Has Continued To Grow And Branch Out 
2016Wobbles Aside, Small Pharma Shares Broadly On The Up In 2015 
Chart ASPEN PHARMACARE HOLDINGS LIMITED
Duration : Period :
Aspen Pharmacare Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASPEN PHARMACARE HOLDINGS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 259  ZAR
Spread / Average Target 49%
EPS Revisions
Managers
NameTitle
Stephen Bradley Saad Group Chief Executive Officer & Executive Director
Douglas Dlamini Chairman
Lorraine Hill Group Operating Officer
Sean Capazorio Group Finance Officer
Michael Guy Attridge Executive Director & Group Deputy CEO
Sector and Competitors